This is a preview of subscription content, log in via an institution to check access.
Notes
see Reactions 1728 p6; 803356137
Reference
Gottlieb S. Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA's efforts to hold industry accountable for fulfilling critical post-marketing studies of the benefits, safety of new drugs. Internet Document : 16 Nov 2018. Available from: URL: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626090.htm
Rights and permissions
About this article
Cite this article
Post-approval studies in US are "vital to enhancing patient safety". Reactions Weekly 1730, 3 (2018). https://doi.org/10.1007/s40278-018-54903-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-54903-8